These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37902006)

  • 21. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
    Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery.
    Kamada T; Haruki K; Nakashima K; Takahashi J; Nakaseko Y; Suzuki N; Ohdaira H; Eto K; Ikegami T; Suzuki Y
    Surg Today; 2023 Sep; 53(9):1064-1072. PubMed ID: 36725756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Yang M; Tang M; Song CH; Deng L; Shi H
    Inflamm Res; 2022 Nov; 71(10-11):1305-1313. PubMed ID: 35962796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
    Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
    Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer.
    Hwang EC; Hwang IS; Yu HS; Kim SO; Jung SI; Hwang JE; Kang TW; Kwon DD; Park K; Ryu SB
    Jpn J Clin Oncol; 2012 Oct; 42(10):955-60. PubMed ID: 22844127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
    Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
    J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
    Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
    Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.
    Sakaguchi T; Maeda K; Takeuchi T; Mizuno A; Kato R; Ishida Y; Ueshima J; Shimizu A; Amano K; Mori N
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):370-379. PubMed ID: 38115133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
    Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    Tominaga T; Nonaka T; Sumida Y; Hidaka S; Sawai T; Nagayasu T
    PLoS One; 2016; 11(12):e0167967. PubMed ID: 27930703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.
    Ghanim B; Schweiger T; Jedamzik J; Glueck O; Glogner C; Lang G; Klepetko W; Hoetzenecker K
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):616-23. PubMed ID: 26242317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
    Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
    Leung EY; Scott HR; McMillan DC
    J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.